| 000 | 01635 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518034950.0 | ||
| 264 | 0 | _c20191025 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1095-8355 | ||
| 024 | 7 |
_a10.1002/cbin.11151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Yan-Feng | |
| 245 | 0 | 0 |
_aVasoactive intestinal peptide inhibits the activation of murine fibroblasts and expression of interleukin 17 receptor C. _h[electronic resource] |
| 260 |
_bCell biology international _cJul 2019 |
||
| 300 |
_a770-780 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCollagen Type III _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibroblasts _ximmunology |
| 650 | 0 | 4 |
_aHydroxyproline _xmetabolism |
| 650 | 0 | 4 |
_aLipopolysaccharides _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNIH 3T3 Cells |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Interleukin _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Interleukin-17 _ximmunology |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome _ximmunology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
| 700 | 1 | _aZhang, Jun | |
| 700 | 1 | _aSun, Chen-Chen | |
| 700 | 1 | _aTang, Chun-Yan | |
| 700 | 1 | _aSun, Guo-Ying | |
| 700 | 1 | _aLuo, Wan-Jun | |
| 700 | 1 | _aZhou, Yong | |
| 700 | 1 | _aGuan, Cha-Xiang | |
| 773 | 0 |
_tCell biology international _gvol. 43 _gno. 7 _gp. 770-780 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cbin.11151 _zAvailable from publisher's website |
| 999 |
_c29629105 _d29629105 |
||